These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis. Yuan Y, Qu B, Yan J, Wang H, Yin L, Han Q. Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821 [Abstract] [Full Text] [Related]
24. Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Wong SH, Kwong TNY, Chow TC, Luk AKC, Dai RZW, Nakatsu G, Lam TYT, Zhang L, Wu JCY, Chan FKL, Ng SSM, Wong MCS, Ng SC, Wu WKK, Yu J, Sung JJY. Gut; 2017 Aug; 66(8):1441-1448. PubMed ID: 27797940 [Abstract] [Full Text] [Related]
25. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression. Komor MA, Bosch LJ, Coupé VM, Rausch C, Pham TV, Piersma SR, Mongera S, Mulder CJ, Dekker E, Kuipers EJ, van de Wiel MA, Carvalho B, Fijneman RJ, Jimenez CR, Meijer GA, de Wit M. J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980 [Abstract] [Full Text] [Related]
26. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan. Ou CH, Kuo FC, Hsu WH, Lu CY, Yu FJ, Kuo CH, Wang JY, Wu MT, Shiea J, Wu DC, Hu HM. J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988 [Abstract] [Full Text] [Related]
28. Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer. Mulder SA, van Leerdam ME, van Vuuren AJ, Francke J, van Toorenenbergen AW, Kuipers EJ, Ouwendijk RJ. Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):878-82. PubMed ID: 17873612 [Abstract] [Full Text] [Related]
29. The influence of lifestyle factors on fecal volatile organic compound composition as measured by an electronic nose. Bosch S, Lemmen JP, Menezes R, van der Hulst R, Kuijvenhoven J, Stokkers PC, de Meij TG, de Boer NK. J Breath Res; 2019 Jun 25; 13(4):046001. PubMed ID: 31170704 [Abstract] [Full Text] [Related]
30. Volatile organic compounds as new biomarkers for colorectal cancer: a review. Di Lena M, Porcelli F, Altomare DF. Colorectal Dis; 2016 Jul 25; 18(7):654-63. PubMed ID: 26752703 [Abstract] [Full Text] [Related]
32. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients. Vasilyev S, Smirnova E, Popov D, Semenov A, Eklund C, Hendolin P, Paloheimo L, Syrjänen K. Anticancer Res; 2015 May 25; 35(5):2873-80. PubMed ID: 25964570 [Abstract] [Full Text] [Related]
39. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Dragonieri S, Annema JT, Schot R, van der Schee MP, Spanevello A, Carratú P, Resta O, Rabe KF, Sterk PJ. Lung Cancer; 2009 May 25; 64(2):166-70. PubMed ID: 18834643 [Abstract] [Full Text] [Related]